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Abstract
Background: Shoulder pain is a highly prevalent complaint and disorders of the rotator cuff, including tears, are thought
to be the most common cause. The number of operations repair the torn rotator cuff has risen significantly in recent
years. While surgical techniques have progressed, becoming less invasive and more secure, rehabilitation programmes
have remained largely like those initially developed when surgical techniques were less advanced and more invasive.
Uncertainty remains in relation to the length of post-surgical immobilisation and the amount of early load permitted at
the repair site. In the context of this uncertainty, current practice is to follow a generally cautious approach, including long
periods of immobilisation in a sling and avoidance of early active rehabilitation. Systematic review evidence suggests early
mobilisation might be beneficial but further high-quality studies are required to evaluate this.
Methods/design: RaCeR is a two-arm, multi-centre pilot and feasibility randomised controlled trial with nested qualitative
interviews. A total of 76 patients with non-traumatic rotator cuff tears who are scheduled to have a surgical repair will be
recruited from up to five UK NHS hospitals and randomly allocated to either early patient-directed rehabilitation or
standard rehabilitation that incorporates sling immobilisation. RaCeR will assess the feasibility of a future, substantive,
multi-centre randomised controlled trial to test the hypothesis that, compared to standard rehabilitation incorporating
sling immobilisation, early patient-directed rehabilitation is both more clinically effective and more cost-effective. In
addition, a sample of patients and clinicians will be interviewed to understand the acceptability of the interventions and
the barriers and enablers to adherence to the interventions.
Discussion: Research to date suggests that there is the possibility of reducing the patient burden associated with post-
operative immobilisation following surgery to repair the torn rotator cuff and improve clinical outcomes. There is a clear
need for a high-quality, adequately powered, randomised trial to better inform clinical practice. Prior to a large-scale trial,
we first need to undertake a pilot and feasibility trial to address current uncertainties about recruitment, retention and
barriers to adherence to the interventions, particularly in relation to whether patients will be willing to begin moving their
arm early after their operation.
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Background
Shoulder pain is a highly prevalent complaint and disor-
ders of the rotator cuff (RC) are thought to be the most
common cause [1]. Overall, the prevalence of RC abnor-
malities, including RC tears, increases with age, from
9.7% in patients under 20 years to 62% in patients over
80 years [2]. Typically, shoulder pain is initially treated
using non-surgical means, including, for example, pain
medication and physiotherapist-led exercise. However, if
symptoms persist and the patient has a RC tear con-
firmed on a scan, then surgery might be considered [3].
In 2017/18, 18,237 patients with RC syndrome, including
tears, were admitted to hospital in the UK’s National
Health Service (NHS) [4].
Surgical techniques to repair the RC have progressed
over time. They have become less invasive and the
repairs have become more secure, raising the possibility
of more rapid patient recovery [5, 6]. Despite surgical
progression, our understanding of the optimal approach
to post-operative rehabilitation, a critical component of
the recovery process, is poor [6]. Rehabilitation pro-
grammes have remained largely like those initially devel-
oped when surgical techniques were less advanced and
more invasive [7]. There is uncertainty about two related
issues: (1) the length of post-surgical immobilisation and
(2) the amount of early load permitted at the repair site
[3]. In the context of this uncertainty, current practice is
to follow a generally cautious approach, including long
periods of immobilisation in a sling (of more than 1
month) and avoidance of active rehabilitation or move-
ment [7], possibly due to fear of failure or re-tear of the
repair site. However, such long periods of shoulder
immobilisation impact significantly on patient’s quality
of life, including their ability to care for themselves,
drive and work.
Furthermore, long periods of immobilisation of the
shoulder after surgery may result in stiffness and weak-
ness and delay functional recovery, and, moreover, they
may actually be detrimental to healing. Improved clinical
outcomes, including reduced length of hospital stay,
have been reported in other areas of orthopaedic and
musculoskeletal rehabilitation with early mobilisation,
for example for ankle sprains and joint replacements,
without compromising healing [8, 9]. A systematic
review and meta-analysis of 12 studies concluded that
concerns about the early initiation of rehabilitation fol-
lowing RC surgical repair might not be warranted in
terms of adverse patient-reported outcomes or tendon
re-tear, but these trials were heterogeneous and too
small to detect small to moderate differences between
groups [10]. Seven of the 12 studies [9, 11–16] evaluated
early versus delayed initiation of rehabilitation. Typically,
this referred to initiation of passive range of movement
exercise (i.e. with no or minimal load), with the excep-
tion of Klintberg et al. [9], who commenced low-level
active range of movement exercises from day 2 post-op-
eratively. These studies suggest that early initiation of re-
habilitation does not adversely affect pain and disability
outcomes in the short (3 months), mid (6 months) or
long term (12 months). However, one randomised con-
trolled trial (RCT), regarded as low quality due to lack
of both allocation concealment and intention-to-treat
analysis, suggested that early initiation of rehabilitation
might favourably affect pain and disability outcomes in
the short term (4 months) [13]. Five of the 12 studies
[11, 12, 14–16] (n = 469) evaluated early versus delayed
initiation of rehabilitation and reported outcomes in
terms of rate of RC tendon re-tear. The pooled odds
ratio of tendon re-tear in the early rehabilitation group
was 1.3 (95% confidence interval: 0.72–2.2; p = 0.41),
which suggests that patients undergoing early rehabilita-
tion were slightly more likely to have a tendon re-tear
than those in the delayed rehabilitation group but the
difference was not statistically significant. Subsequent to
the systematic review, a Canadian RCT (n = 189) com-
pared early rehabilitation (patient-led mobilisation or
movement of the shoulder) with sling immobilisation
following RC repair [17]. This trial did not restrict inclu-
sion by size of RC tear and concluded that the range of
movement of the shoulder was better at 6 weeks in the
early rehabilitation group, but there were no significant
differences between groups at 3, 6, 12 or 24 months,
indicating that early rehabilitation might result in a
faster recovery without detrimental effects in the longer
term. In addition, Mazuquin et al. [18] conducted a
review of systematic reviews and concluded that early
mobilisation might be beneficial but suggested more
high-quality studies are required, especially for patients
with large tears.
Methods/design
This protocol is reported with reference to the SPIRIT
checklist (Additional file 1) [19].
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Study design
The RaCeR study is designed as a two-arm, multi-centre
pilot and feasibility RCT with nested qualitative inter-
views (Figs. 1 and 2).
Aim
In patients undergoing surgical repair of the RC, we aim
to assess the feasibility of a future, substantive,
multi-centre RCT to test the hypothesis that, compared
to delayed rehabilitation incorporating sling immobilisa-
tion, early patient-directed rehabilitation is both more
clinically effective and more cost-effective.
Objectives
The objectives of this pilot and feasibility RCT are as
follows:
1) To determine the availability of eligible patients and
the rate of recruitment.
2) To determine the rate of retention and the
response rates to questionnaires and SMS text
messages.
3) To determine whether the interventions can be
delivered per protocol, including an assessment of
adherence, i.e. the time out of sling for both the
early rehabilitation group and the sling
immobilisation group.
4) Determine the primary outcome measure for the
main trial by evaluating sensitivity to change and
assess other statistical properties related to
clinical outcomes (e.g. standard deviation,
betweenmeasurement correlations, event rate)
that would be required to inform the sample size
calculation for a main trial as well as an
assessment of the completeness of follow-up
between different methods of data capture
(questionnaire and SMS text),
5) Determine rate of response and completion of
healthcare resource use questionnaire and
productivity, including return to work,
6) Explore participant satisfaction with interventions,
7) Determine rate of tendon re-tear or failed
healing (same outcome that RC is not intact) at
12-weeks post-surgery determined via diagnostic
ultrasound,
8) Determine number and nature of adverse events via
self-report questionnaire.
Semi-structured qualitative interviews will be undertaken:
1) To determine the acceptability of the interventions
to patients and clinicians.
2) To identify the barriers and enablers to adherence.
3) To identify which outcome measures best reflects
the participants’ rehabilitation goals.
Study setting
Patients will be recruited from orthopaedic departments
of the participating UK NHS hospitals. Following sur-
gery to repair the RC, the study interventions will be
delivered prior to discharge while the patient is on the
hospital ward. Subsequent components of the study in-
terventions will be delivered through outpatient physio-
therapy settings in, or affiliated to, the main hospitals.
Participants
Inclusion criteria
Patients can be included if they meet all of the following
criteria:
1) They have been diagnosed with a non-traumatic
symptomatic tear of the RC and listed for surgical
repair.
2) They have RC tear that has been confirmed by
ultrasound or magnetic resonance imaging (MRI).
3) They are aged ≥18 years.
4) They have been screened by a surgeon as suitable
for participation.
5) They can return to the recruiting centre or
affiliated site for the initial outpatient follow-up
physiotherapy appointment.
6) They have access to a mobile phone and are willing
and able to receive and respond to SMS text
messages
7) They understand English.
Exclusion criteria
Patients are excluded if they met any of the following
criteria:
1) They have a traumatic RC tear (e.g. sudden onset of
shoulder pain and weakness following a fall). Given
the different care pathways in the UK, such patients
are typically fast-tracked to surgery.
2) They unable to give full informed consent.
Recruitment
Potential participants will be identified from the surgical
waiting list by a hospital-based research health-care practi-
tioner (e.g. a nurse, physiotherapist or radiographer) and
screened with reference to the inclusion and exclusion cri-
teria. If potentially eligible, they will be sent in the post
from the NHS hospital an invitation to participate in the
study, an explanatory letter and a participant information
sheet. These will include contact details of the research
health-care practitioner. They will then be followed up by
the research health-care practitioner within approximately
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Fig. 1 Study flow chart
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1 week by telephone (up to three attempts) or at a different
time if the patient wishes to initiate the telephone call. If
during screening including the telephone call, the patient
indicates an interest in being involved or wishes to have
further time to consider, they will be invited to discuss par-
ticipation in the study further with the research health-care
practitioner at the time of the pre-operative clinic appoint-
ment or another convenient time. For patients who cannot
be contacted over the telephone, a follow-up letter will be
sent asking them to make contact with the research
health-care practitioner at the time of their pre-operative
assessment should they be interested.
This discussion will build on a recent successful
six-step model to promote recruitment to RCTs that re-
sulted in 57% recruitment of eligible patients in an
orthopaedic setting [20], and will include: (1) an explan-
ation of the condition, (2) reassurance about receiving
treatment, (3) telling the patient about the uncertainty
in what is the most effective approach to rehabilitation
to highlight reasons why the research is necessary, (4) an
explanation of the purpose of the study, (5) a balanced
view of the two interventions after surgery and (6) an
explanation of study procedures including randomisa-
tion and follow-up requirements. This process will be
supported by a recruitment script written for the
research health-care practitioner, which they can refer to
during both the initial telephone call and the subsequent
pre-operative clinic appointment.
During the telephone call, medical note review and
face-to-face meeting, the patient’s age and year of birth,
Fig. 2 Schedule of enrolment, interventions, and assessments (SPIRIT Statement) [19]
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gender, diagnosis, size and location of RC tear and, if
applicable, reason for exclusion will be collected. Once
patients have been identified, and it is confirmed that
they have a symptomatic RC tear and are 18 years or
older, the research health-care practitioner will check
their medical notes to confirm that the surgeon respon-
sible for their care does not wish them to be excluded
from participation in the study prior to contacting them.
This checking process will be documented.
Interested and eligible patients will be required to pro-
vide written informed consent before participating. Typ-
ically, written informed consent will be sought at the
time of the pre-operative assessment or other convenient
time prior to surgery. A research health-care practi-
tioner, who will have received appropriate training and is
authorised on the trial delegation log, will take informed
consent. A record of the consent process will be kept in
the patient’s medical records. The original consent form
will be retained in the study site file and a copy will be
given to the participant. A copy will also be securely sent to
Keele Clinical Trials Unit (CTU) for monitoring purposes.
Participants have the right to withdraw at any time
without any consequence to any future care they may re-
quire. For each trial participant, their general practi-
tioner will be sent a letter from Keele CTU to confirm
that their patient is taking part in the research study.
Data collection
The research health-care practitioner will provide the
baseline questionnaire to consenting patients for them
to complete themselves. This collects demographic data,
general practitioner details, the Oxford Shoulder Score
(OSS), the Shoulder Pain and Disability Index (SPADI)
and EQ-5D-5L. The patient will be given adequate time
and a suitable location to complete the baseline ques-
tionnaire. It will be checked for completeness by the
research health-care practitioner. The original baseline
questionnaire will be sent to Keele CTU and a copy
retained in the study site file. Once the baseline ques-
tionnaire has been completed and checked, the partici-
pant will be randomised to either the intervention or
control group.
The size and location of the tear will be recorded,
since these may be important determinants of the clin-
ical outcome. This information will be collected by the
research health-care practitioner from the pre-operative
imaging, ultrasound scan (USS) or MRI, which will typ-
ically be available in the medical notes. Due to concerns
about the reliability of measurements of the size and
location of a tear by imaging alone, the physiotherapist
who delivers the allocated treatment will record the
intra-operative findings of the size and location of the
tear and the completeness of repair as they will typically
have access to this information. The completeness of the
repair will allow the study team to contextualise the USS
12 weeks post-operatively. Previous studies have been
criticised for reporting re-tears only dichotomously, i.e.
torn or not, whereas a re-tear identified on an USS
might just reflect that the tear was only partially repaired
or not repaired at the time of the operation.
The OSS is a 12-item shoulder-specific self-report
measure of shoulder pain and function, primarily used
to assess the outcome of shoulder surgery in RCTs [21].
The OSS is reliable, valid, responsive and acceptable to
patients [21–23]. The items refer to the past 4 weeks.
Each has five ordinal response options scored from 0 to
4, with 4 representing the best outcome. When the 12
items are summed, this produces an overall score ran-
ging from 0 to 48, with 48 being the best outcome.
The SPADI is a self-report measure of pain and func-
tion in patients with shoulder disorders [24]. It is the
most commonly used outcome measure in trials of con-
servative interventions [25]. The SPADI has been vali-
dated for use with patients who have shoulder pain. A
minimally clinically important change of 10 points has
been identified [24, 26]. Additionally, excellent levels of
reliability (intraclass correlation coefficient 0.66 to 0.95),
high internal consistency (Cronbach’s α typically >0.9)
and responsiveness over time have been reported in tan-
dem with no floor and ceiling effects [26]. The SPADI
has 13 items divided into two sub-scales: pain (5 items)
and disability (8 items). The responses are indicated on
a visual analogue scale where 0 = no pain/no difficulty
and 10 = worst imaginable pain/so difficult it requires
help. The items are summed and converted to a total
score out of 100 where a high score indicates greater
pain and disability.
The EQ-5D-5L is a generic measure of health-related
quality of life. It provides a single index value for health
status that can be used in a clinical or health economic
evaluation [27]. The EQ-5D-5L consists of questions re-
lating to five health domains (mobility, self-care, usual
activities, pain/discomfort and anxiety/depression) and
respondents rate their degree of impairment using five
response levels (no problems, slight problems, moderate
problems, severe problems and extreme problems) [27].
The EQ-5D-5L is the National Institute for Health and
Care Excellence’s preferred measure of health-related
quality of life in adults.
A patient-completed personal exercise diary will be
returned to the treating physiotherapist at the 4-week
follow-up appointment and then returned to Keele
CTU. Alternatively, it can be returned to Keele CTU
along with the 6-week postal questionnaire, if necessary.
The rate of tendon re-tear or failed healing will be
evaluated through a diagnostic USS performed at 12
weeks according to an agreed and standardised protocol
for the sonographers. This information will be compared
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to the pre-operative imaging results and the intra-opera-
tive findings. A diagnostic USS is regarded as a relatively
cheap but accurate modality for identifying RC tears
[28].
The randomisation scheme
Blocked randomisation in a 1:1 ratio will be undertaken
remotely using web-based randomisation supported by
Keele CTU to ensure allocation concealment. Following
confirmation of eligibility, and the receipt of a correctly
completed and signed consent form and a completed
baseline questionnaire, an authorised research health-
care practitioner will access Keele CTU’s secure system
to randomise the participant to one of the two treatment
arms. The randomisation will be performed using ran-
dom permuted blocks and will be blocked by recruiting
site (block sizes of 2 and 4) to ensure that patients at
each centre have an equal chance of receiving either
treatment. The allocation will be placed in a sealed
opaque gold envelope that is attached to the patient’s
medical notes or added as a note to the electronic
patient file, according to the local procedure. The enve-
lope or note will be addressed to the physiotherapist
who will deliver the treatment.
Blinding
The participant will be informed of the allocation only
by the physiotherapist who will deliver the allocated
treatment, and the surgeon will remain unaware of the
allocation until after the surgery to minimise the likeli-
hood of withdrawal through knowledge of the allocated
intervention. No further measures to blind participants,
clinicians, research team or oversight committees will be
implemented in this external pilot and feasibility RCT.
Interventions
Control group Reflective of current UK practice [7],
after surgery, the patient’s shoulder will be immobilised
using a sling for 4 weeks. They will have one session in
the hospital with a physiotherapist, after surgery but
prior to discharge. This session will include advice to
maintain the sling in situ at all times. It should be re-
moved only to perform specific daily exercises (table
slides, active elbow, wrist and hand exercises and passive
shoulder abduction, flexion and lateral rotation move-
ments, within pain limits), or for eating, washing and
dressing. The sling should also be worn at night. No
further active movement will be encouraged. A post-op-
erative information and exercise booklet with photo-
graphs and text detailing the exercise type and number
of sets and repetitions will be provided. This initial dis-
cussion will be followed up approximately 2 weeks later
at an outpatient appointment with the physiotherapist,
who will reconfirm this advice.
Adherence to the programme, i.e. time out of the
sling, will be measured using a personal exercise diary.
This was developed in association with our patient and
public involvement and engagement (PPIE) group and
will be provided by the physiotherapist. Participants will
be asked to record in the diary for how long they were
not wearing the sling at regular periods throughout the
day, in the same way as the intervention group. Partici-
pants will also be asked to record the extent to which they
feel they have adhered to the prescribed exercise plan.
Intervention group The intervention group will
undergo early patient-directed rehabilitation. This in-
cludes one session in hospital with a physiotherapist,
after surgery but prior to discharge. In contrast to the
control intervention, this session will include advice to
remove the post-operative sling, as pain allows, as soon
as possible and gradually to begin actively using the arm
within the limits of their pain. This use will increase
over time according to agreed goals within the context
of the patient’s own pain experience and tolerance. Like
the participants in the control group, participants in the
intervention group will also receive advice to perform
specific daily exercises (table slides, active elbow, wrist
and hand exercises, and passive shoulder abduction and
flexion movements, all within pain limits). However,
given that the intention of the intervention is to encour-
age early movement after surgery, if participants remove
their arm from the sling at times other than to exercise,
then they will not need to do the basic table slides and
active elbow, wrist and hand exercises. Instead, they will
be advised that only shoulder abduction, flexion and lat-
eral rotation movements are required to encourage range
of movement. A post-operative information and exercise
booklet with photographs and text detailing the exercise
type and number of sets and repetitions will be provided.
This initial discussion will be followed up approxi-
mately 2 weeks later at an outpatient appointment with
a physiotherapist to discuss progress, address barriers to
sling removal and active functional shoulder movement,
and to facilitate adherence with the early rehabilitation.
As with the control group, an assessment of the imple-
mentation of and adherence to the intervention will be
facilitated by the personal exercise diary, which the par-
ticipant will use to record the time out of the sling at
regular periods throughout the day. Participants will also
be asked to record the extent to which they feel they
have adhered to the prescribed exercise plan.
Both groups Both groups will be provided with the
same type of sling and advised to take pain medication
as prescribed. Use of medication will be self-reported
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and analysed. After 4 weeks, both groups will commence
1:1 physiotherapy as per current UK practice, which in-
cludes a progressive exercise programme targeting range
of movement, strength and function [7] as follows:
Phase 1: Progress to assisted movement (shoulder
movement with assistance) then full active movement
(shoulder movement by the patient) within pain limits
Phase 2: Isometric exercises (resisted static exercises)
for all shoulder muscle groups
Phase 3: Resisted exercises through range, within limits
of pain
Phase 4: Functional restoration
This physiotherapy protocol has been agreed with all
clinical sites. Progress between the phases will be indivi-
dualised and guided by the patients’ acceptable symptom
response over four further physiotherapy sessions (six in
total) complemented by a home exercise programme.
Delivery of the intervention and control treatments will
be supported by a manual for the physiotherapists.
Study training
Research health-care practitioners will be trained in each
of the participating centres on the participant eligibility
criteria, the approach to recruitment and consent, the
requirements for the completion of all study paperwork,
good clinical practice as applicable to research and the
maintenance of the study site file and study records.
Reporting of serious adverse events and adverse events
will also be covered.
In addition, the clinical physiotherapists, both those
who will initially prescribe the study intervention to pa-
tients on a ward in an in-patient setting and those who
will subsequently assess and treat patients in an out-
patient setting, will be trained prior to the start of re-
cruitment and treatment. Due to the limited number of
clinical physiotherapists within the clinical site teams,
each clinical physiotherapist will treat patients in both
arms. However, given the protocolised nature of the in-
terventions, we do not expect a significant contamin-
ation effect and we will include contamination and how
to avoid it within the study training.
The focus of this training will be on delivery of the in-
terventions and will be supplemented by a comprehen-
sive manual providing clear treatment protocols and
guidance on study paperwork for the clinicians. They
will also receive instruction sheets for the exercises, per-
sonal exercise diaries for participants and post-operative
patient information booklets with information on
returning to usual activities, including driving and work.
The training will take the form of workshops consisting
of information provision, question and answer sessions
and role play with regards to supporting the approach to
early patient-directed rehabilitation and overcoming any
barriers.
The sonographers will undertake the USS of the shoul-
der at 12-weeks to assess whether the RC has re-torn.
The USS will be focused on the RC and details of the
RC tear and surgery will be provided, as described above.
The sonographers will be provided with information re-
garding the RaCeR study and will be offered the oppor-
tunity to discuss the protocol with the research team.
However, because the protocol reflects usual practice in
the UK, further formal training will not be routinely
offered.
Outcomes
Feasibility outcomes
1) Numbers of potentially eligible and eligible
patients, number invited, number attending a
pre-operative assessment clinic and consent rates
(target recruitment is six or seven participants
per month over a 12-month recruitment period)
2) Number of eligible patients found subsequently
during surgery not to have an RC tear (indicating a
false positive scan)
3) Feasibility of recruiting participating centres and
number of additional centres in which staff are
interested in participating in a future main trial
4) Rate of retention in the trial, including response
rates to questionnaires and individual measures
(including resource use) and SMS text messages
5) Intervention fidelity and adherence using
physiotherapist-completed case report forms and
patient-completed personal exercise diaries for time
out of sling
6) Determining the primary outcome measure for the
main trial by assessing and comparing sensitivity to
change of the measures and other statistical
properties to support sample size derivation,
comparing follow-up rates of different methods of
data capture (questionnaire/SMS text) and of
individual measures, and evaluating which outcome
measures best reflect the patients' rehabilitation
goals, identified from the qualitative interviews,
7) Participant satisfaction with the interventions on a
five-point ordinal scale, ranging from very satisfied,
satisfied, neutral and dissatisfied to very dissatisfied
8) Patient and clinician views about the acceptability
of the interventions (qualitative data)
Clinical outcomes
1) Pain and disability assessed using the OSS and
SPADI at baseline, 6 weeks post-surgery by post
and 12 weeks post-surgery in person during a
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follow-up clinic visit or by postal questionnaire, or
by telephone call to collect minimal data if there is
no response to the postal questionnaire
2) Health-related quality of life assessed using the EQ-
5D-5L at baseline, 6 weeks post-surgery by post and
12 weeks post-surgery in person during a follow-up
clinic visit or by postal questionnaire
3) Global change question at 6 weeks post-surgery by
post and 12 weeks post-surgery in person during a
follow-up clinic visit or by postal questionnaire, or
by telephone call to collect minimal data if there is
no response to the postal questionnaire
4) Pain in the last week (derived from the OSS) using
weekly SMS text messages for 12 weeks post-
surgery based on a 0–4 numerical rating scale with
anchors of no pain (0) to unbearable pain (4)
5) Disability relating to work or activity interference
due to the shoulder problem in the last week
(derived from the OSS) using weekly SMS text
messages for 12 weeks post-surgery based on a 0–4
numerical rating scale with anchors of not at all (0)
to totally (4)
6) Days lost from work due to the shoulder problem
at 6 weeks post-surgery via postal questionnaire and
12 weeks post-surgery via questionnaire completed
during a follow-up clinic visit
7) Time taken to return to driving, if applicable, via a
questionnaire at the 6- and 12-week follow-ups
8) Number and type of adverse events, e.g. post-
procedural exacerbation of pain, for up to 12 weeks
post-randomisation via patient self-report
questionnaire at 6 and 12 weeks post-surgery and
via surgeon, physiotherapist or general practitioner
report
9) Diagnostic USS performed by a sonographer
independent of the study to assess the integrity of
surgical repair at 12 weeks post-surgery
We will also collect self-report data relating to further
health-care resource use, including NHS- and private-
borne service and medication costs as well as data from
the surgery itself, including the completeness of the surgi-
cal repair, and questions relating to the patient’s occupa-
tion and their loss or gain of productivity at work.
Sample size calculation
Although RaCeR is a pilot and feasibility RCT, a sample
size calculation has been conducted to ensure there is a
sufficient number of participants to detect a difference in
time out of sling between the two randomised groups. Un-
derstanding this is a key feasibility objective and will be an
important factor in determining whether a future main
trial is feasible. Randomising 76 participants, which allows
for 20% missing adherence-related data (time out of sling
captured using the personal exercise diaries), will provide
90% power to allow us to detect at least a minimum 40%
difference in sling use between the two arms, given a
1-sided 5% significance level. Randomising 76 participants
will enable us to estimate the 1-sided lower 90% confidence
limit for the follow-up rate to within about 6% of the antici-
pated 80% level. Further, a sample size of about 76, allowing
for dropouts, will be sufficient to allow precise calculation
of estimates of the standard deviations around potential
primary clinical outcomes for a future main trial [29].
Planned recruitment rate
The planned recruitment rate is six or seven partici-
pants per month over a 12-month period to reach the
target of 76.
Statistical analysis plan
As this is a pilot and feasibility RCT, the main analysis
will focus on process outcomes and will estimate the
number of potentially eligible patients, the number and
rate of eligible patients, the consent rate, the overall up-
take rate (in relation to the number potentially eligible),
the retention rate, follow-up rates for questionnaires and
texts, and adherence to the interventions, including time
out of sling. We will calculate means and confidence in-
tervals of clinical outcomes (both within- and between-
study groups) and determine which outcomes are most
sensitive to change. We will evaluate the parameters
required to inform the sample size calculation for a fu-
ture main trial. A detailed statistical analysis plan will be
developed by the study statistician and agreed by the
trial steering committee.
At the end of the study, we will review the findings
and in discussion with the trial steering committee, we
will make a recommendation about proceeding to a
future main trial. The following success criteria will be
used to decide whether to make an application for fund-
ing for a main trial:
i.) Recruitment rates: Randomisation after consent of
20% or more of eligible patients
ii.) Intervention adherence: Difference in time out of
sling of 40% or more, i.e. the early rehabilitation
(intervention) group will report 40% more time out
of the sling than the control group in the first 4
weeks after surgery
iii.) Follow-up rates for the potential main outcome
measures >70% for questionnaires at 6 and 12
weeks and weekly for the SMS text messages
Patient and public involvement and engagement
We have held three structured PPIE group meetings
facilitated by the lead researcher (CL). One group com-
prised patients who had undergone surgery to repair
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their RC and the other two meetings were with experi-
enced PPIE members drawn from the Research User
Group at Keele University. Additionally, one PPIE mem-
ber (TC) is a co-applicant and co-author and continues
to contribute to this project regularly.
The aims of PPIE were multiple, including developing
study processes (for example, recruitment), developing
patient-facing materials (for example, the participant in-
formation sheets) and contributing to study manage-
ment and oversight (for example, membership of the
trial management group and trial steering committee).
PPIE resulted in development of the process of recruit-
ment whereby it was suggested that recruitment and the
process of informed consent be moved away from the
clinical consultation to a separate time facilitated by a
research healthcare practitioner. Study materials, for ex-
ample the personal exercise diary, were also developed
to be more user-friendly.
PPIE has resulted in tangible outcomes that will facili-
tate study delivery, including recruitment and data col-
lection. In addition, PPIE has an ongoing and important
contribution to trial management and oversight [30].
Qualitative interviews
We anticipate interviewing up to 10 patient participants
from each of the two groups (up to n = 20 in total) and
up to 10 clinician participants (shoulder surgeons
(approximately n = 3), physiotherapists (n = 4) and
nurses (approximately n = 3)) involved in explaining the
trial to patients, conducting the screening and consent
processes, or delivering the intervention. We expect that
this number of patients and clinicians will be sufficient to
reach data saturation. We will cover similar topics with all
interviewees, to ensure that we can compare their re-
sponses, while at the same time enabling them to reflect on
their specific expectations, understanding and experiences.
Information about the qualitative interviews will be in-
cluded in the initial RCT participant information sheet.
The RCT consent form will include consent for the pa-
tient to be contacted post-surgery to discuss their par-
ticipation. Patients will be purposefully sampled
post-surgery with respect to their allocated treatment
group and their pain and disability status according to
early SMS text message responses. They will then be
contacted by telephone to discuss their further participa-
tion in the qualitative study. If a patient wishes to par-
ticipate, then a participant information sheet pertaining
specifically to the qualitative study and a consent form
will be posted to them with a pre-paid envelope. On re-
ceipt of their written informed consent, a mutually con-
venient time to conduct the interview will be arranged.
Patients may decline to participate in the interviews yet
still be involved in the trial.
The clinicians will be informed of the interviews dur-
ing the initial site set-up and follow-up visits. Clinician
participant information sheets and consent forms will be
provided, allowing them to consent to be contacted. If a
clinician consents to be contacted, the research team
will subsequently contact them with a view to discussing
participation once they have gained experience in
explaining the trial to patients, in the screening and con-
sent processes, or in delivering the intervention. If a
clinician wishes to participate then, on receipt of their
written informed consent, a mutually convenient time to
conduct the interview will be arranged.
Patient participants will be interviewed around 4
weeks after their surgery. The interviews will last for
approximately 45 minutes and be face-to-face or by tele-
phone. All interviews will be conducted by an experi-
enced qualitative researcher and will be based on
semi-structured topic guides developed in association
with our PPIE group. A similar process will be followed
for the clinician participants.
With the participants’ consent, interviews will be
audio-recorded and transcribed verbatim. In the unlikely
event that an audio-recording is of poor quality, the par-
ticipant will be re-contacted and invited to a second
interview. The interviews will be sent securely to and
transcribed by a professional transcription company,
which operates under the terms of a confidentiality
agreement. Transcripts will be anonymised during the
transcription process.
Interviews will be analysed both thematically (indexing
key themes and contextualising these in the broader data
set) and as narratives (capturing the patient journey for
each patient participant). This approach ensures that the
context of individual patient journeys is preserved while
supporting a broader thematic analysis [31]. The soft-
ware NVivo will be used. We will develop an appropriate
coding strategy and coding framework that facilitates
data retrieval and comparative analyses [32].
Discussion
The evidence to date suggests there is the potential to
reduce the patient burden associated with post-operative
immobilisation following surgery to repair a torn RC
and to improve clinical outcomes. The principal concern
about early rehabilitation is the perceived risk of re-tear-
ing the repaired RC, but this concern might be un-
founded. Given an ageing population, the increasing
prevalence of RC disorders, the rising rates of RC sur-
gery and preliminary evidence that early rehabilitation
might improve clinical outcomes, further research is
now needed. There is a clear need for a high-quality,
adequately powered, randomised trial evaluating out-
comes including pain, disability and the re-tear rate to
inform clinical practice. Prior to the main trial, this
Littlewood et al. Trials          (2019) 20:328 Page 10 of 12
RaCeR pilot and feasibility trial will first address the
current uncertainties about recruitment, retention and
adherence with the intervention, particularly in relation
to whether patients will be willing to begin moving their
arm early after their operation.
Trial status
At the time of submission of this protocol paper, RaCeR
(protocol version 2.0 dated 26 July 2018) was open to
recruitment (commenced recruitment 21 November
2018). Recruitment is scheduled to be complete by 20
November 2019.
Additional file
Additional file 1: SPIRIT 2013 Checklist: Recommended items to
address in a clinical trial protocol and related documents. (DOC 119 kb)
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